What Price Transparency Data Teaches Us About Keytruda

What can we learn from price transparency data for physician-administered drugs? New data on Keytruda highlights wide variation in commercial reimbursement: across states, by payer, and based on provider characteristics like place of service. A single treatment for this high-cost infusion can range from under $12,000 to over $30,000, depending on where it’s given, which payer is involved, and how it’s billed.